Pular para o conteúdo principal

Deficiência de fosfoglicerato quinase 1

Esta página foi arquivada.

Não foi revisado recentemente e não está atualizado. Links externos e referências podem não funcionar mais.

Profissionais de Saúde

Os artigos de Referência Profissional são projetados para uso por profissionais de saúde. Eles são escritos por médicos do Reino Unido e baseados em evidências de pesquisa, diretrizes do Reino Unido e da Europa. Você pode encontrar um dos nossos artigos de saúde mais útil.

Synonyms: Phosphoglycerokinase deficiency, PGK deficiency, PGK1 deficiency, Haemolytic anaemia with PGK Deficiency,

Phosphoglycerate kinase deficiency is a hereditary metabolic disease. Phosphoglycerate kinase (PGK1) is a ubiquitous glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate generating one molecule of ATP. Its gene lies on the X-chromosome (locus Xq13) and there are related pseudogenes on the X-chromosome and chromosome 19.1

It is a complex enzyme: several subtypes of deficiency have been identified,2 based on the tissues in which the enzyme deficiency occurs and the type of inheritance. Clinically, there are two distinct syndromes:

  • A pure muscle syndrome characterized by recurrent cramps and muscle breakdown in response to intense exercise.3

  • A "muscle plus" syndrome which may feature mental retardation and/or haemolytic anaemia.

Different mutations of the erythrocyte enzyme PGK1 gene have been identified but the reason for the multifarious clinical manifestations of mutations of the same gene remains unknown.4

Epidemiologia

  • It is extremely rare.

  • The gene encoding the erythrocyte enzyme PGK1 is X-linked and PGK is transmitted as an X-linked recessive disorder in nearly 75%. Females are carriers and have a 50% chance of transmitting the gene to an affected son or a carrier daughter. Affected males produce carrier daughters and unaffected sons.

  • It is inherited as an autosomal recessive in about 25%.5

Apresentação

  • Presentation is variable but occurs between infancy and adolescence.

  • Clinical findings include:

    • Muscle pain and weakness

    • Rust-coloured urine after vigorous exercise due to myoglobinuria

  • Other features are rare and highly variable but may include:

    • Nausea after exercise

    • Variable degrees of mental retardation

    • Convulsões

    • Anemia hemolítica

  • Some patients may have a purely myopathic syndrome with progressive proximal muscle weakness and episodes of myoglobinuria, exercise intolerance and easy fatigue.

  • There can be emotional lability, aphasia with impaired ability to comprehend speech or writing and hemiplegia.

  • Female carriers may have haemolytic anaemia.

Diagnóstico diferencial

There are a number of enzyme defects that can cause myoglobinuria6 as well as other causes to remember:

  • Biochemical abnormalities (eg hipocalemia, hypophosphataemia)

  • Miopatias

  • McArdle's disease (Glycogen storage disorder V) and Tarui's disease (Glycogen storage disorder VII)

  • Acetyl-CoA dehydrogenase deficiency and lactate dehydrogenase deficiency

  • Polimiosite e dermatomiosite

  • Hipertermia maligna

  • síndrome neuroléptica maligna

  • Síndrome de esmagamento

  • Muscle ischaemia secondary to arterial occlusion or insufficiency

  • Septicemia

  • Drug abuse

Investigações

  • Diagnostic testing is available for the absence of the enzyme phosphoglycerate kinase.

  • There is recurrent myoglobinuria, especially after exercise.

  • Serum CK levels are high or normal.

  • Anaerobic exercise produces no rise in lactate.

  • Gene mutation identification within family groups.

Gestão

Non-Drug

Strenuous exercise should be avoided.

Medicamentos

None are of proven value.

Cirurgia

Splenectomy can reduce the haemolytic anaemia and the need for transfusion.7

Complicações

Myoglobinuria from prolonged exercise can produce renal damage.

Prognóstico

Severity varies but the myopathic syndrome is usually slowly progressive. In one study of a large family, many sufferers died before reaching adulthood.8

Prevenção

Identification of the gene9 may permit prenatal diagnosis with a view to termination of pregnancy.

Atualizações exclusivas para profissionais de saúde

Mantenha-se informado com as últimas atualizações clínicas, insights profissionais e orientações baseadas em evidências. O boletim informativo Patient Pro seleciona conteúdo essencial para profissionais de saúde—entregue diretamente na sua caixa de entrada.

Por favor, insira um endereço de e-mail válido

Ao se inscrever, você aceita nossos Política de Privacidade. Você pode cancelar a inscrição a qualquer momento. Nunca vendemos seus dados.

Leitura adicional e referências

  1. Phosphoglycerate Kinase-1 Deficiency, Online Mendelian Inheritance in Man (OMIM)
  2. Tsujino S, Shanske S, DiMauro S; Molecular genetic heterogeneity of phosphoglycerate kinase (PGK) deficiency. Muscle Nerve. 1995;3:S45-9.
  3. Spiegel R, Gomez EA, Akman HO, et al; Myopathic form of phosphoglycerate kinase (PGK) deficiency: A new case and pathogenic considerations. Neuromuscul Disord. 2009 Jan 19.
  4. Beutler E; PGK deficiency. Br J Haematol. 2007 Jan;136(1):3-11.
  5. Phosphoglycerate Kinase (PGK) 1 Deficiency, Online Mendelian Inheritance in Man (OMIM)
  6. Tonin P, Lewis P, Servidei S, et al; Metabolic causes of myoglobinuria. Ann Neurol. 1990 Feb;27(2):181-5.
  7. Fujii H, Miwa S; Other erythrocyte enzyme deficiencies associated with non-haematological symptoms: phosphoglycerate kinase and phosphofructokinase deficiency. Baillieres Best Pract Res Clin Haematol. 2000 Mar;13(1):141-8.
  8. Turner G, Fletcher J, Elber J, et al; Molecular defect of a phosphoglycerate kinase variant associated with haemolytic anaemia and neurological disorders in a large kindred. Br J Haematol. 1995 Sep;91(1):60-5.
  9. Flanagan JM, Rhodes M, Wilson M, et al; The identification of a recurrent phosphoglycerate kinase mutation associated with chronic haemolytic anaemia and neurological dysfunction in a family from USA. Br J Haematol. 2006 Jul;134(2):233-7. Epub 2006 Jun 1.

Sobre o autor

Imagem do autor

Dra. Chloe Borton, MRCGP

BA, PGCE, MBBS, DFFP, MRCGP

Sobre o revisorVer biografia completa

Imagem do autor

Equipe de clínicos e pacientes

A equipe clínica do Patient.info cria e revisa nosso conteúdo de saúde para garantir que seja preciso, baseado em evidências e guiado por padrões confiáveis do NHS e NICE.

Histórico do artigo

As informações nesta página são escritas e revisadas por clínicos qualificados.

verificador de elegibilidade para gripe

Pergunte, compartilhe, conecte-se.

Navegue por discussões, faça perguntas e compartilhe experiências em centenas de tópicos de saúde.

verificador de sintomas

Sentindo-se mal?

Avalie seus sintomas online gratuitamente